Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 29, 2023

Novel Labs Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?

NOVEL LABS INC has sixty approved drugs.

There are three tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc

US Patents:	0
Tradenames:	45
Ingredients:	44
NDAs:	60

Drugs and US Patents for Novel Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION;ORAL	090019-001	May 27, 2009		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	TINIDAZOLE	tinidazole	TABLET;ORAL	202044-002	Apr 30, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	MORPHINE SULFATE	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	203602-001	Dec 16, 2015	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	TEMAZEPAM	temazepam	CAPSULE;ORAL	071456-001	Apr 21, 1987	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	206142-003	Nov 14, 2016	AA	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	CEVIMELINE HYDROCHLORIDE	cevimeline hydrochloride	CAPSULE;ORAL	204746-001	Dec 30, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Novel Labs Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, CHEWABLE;ORAL	204115-003	Feb 25, 2015		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Baxter

Medtronic

Mallinckrodt

Dow

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.